INmune Bio
INMB
INMB
73 hedge funds and large institutions have $29.6M invested in INmune Bio in 2024 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 35 increasing their positions, 6 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
4.39% more ownership
Funds ownership: 24.15% → 28.54% (+4.4%)
2% more capital invested
Capital invested by funds: $28.8M → $29.6M (+$702K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
73
Holding in Top 10
1
Calls
$1.78M
Puts
$379K
Top Buyers
| 1 | +$485K | |
| 2 | +$463K | |
| 3 | +$435K | |
| 4 |
Renaissance Technologies
New York
|
+$410K |
| 5 |
Morgan Stanley
New York
|
+$328K |
Top Sellers
| 1 | -$410K | |
| 2 | -$329K | |
| 3 | -$313K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$216K |
| 5 |
Squarepoint
New York
|
-$182K |